Identification of Microbe-Drug Association based on Weighted Profile and Collaborative Matrix Factorization

Q4 Biochemistry, Genetics and Molecular Biology
Zhu Ling-zhi, Guixiang Li, Chunhua Li, Jun Wang
{"title":"Identification of Microbe-Drug Association based on Weighted Profile and Collaborative Matrix Factorization","authors":"Zhu Ling-zhi, Guixiang Li, Chunhua Li, Jun Wang","doi":"10.3844/ajbbsp.2021.502.508","DOIUrl":null,"url":null,"abstract":"Corresponding Author: Ying Xiao Hunan Chemical Vocational Technology College, Zhuhou, China Email: lingzhi0825@yeah.net Abstract: Previous studies have shown that diseases are associated with microbe. To explore a more effective treatment for these diseases, unknown microbe-drug associations must be identified. However, existing models to identify microbe-drug association are limited. In our article, a predictive model (WPCMF) is presented for identifying microbe-drug associations based on weighted profile and collaborative matrix factorization. In WPCMF, the Gaussian Interaction Profile (GIP) can be used for computing the similarities of microbe and the drug, respectively. Then we use the Canonical SMILES of drugs to compute the chemical structures similarity of drugs. Two drug similarities are fused into an integrated drug similarity matrix. Weighted profile and collaborative matrix factorization are applied for predicting potential microbe-drug associations. Experimental results show that WPCMF achieves the average Area Under the Curve (AUC) values of 0.9096±0.0028, 0.9195±0.0019 and 0.9236 in 5-fold Cross-Validation (5 CV), 10-fold Cross-Validation (10 CV) and Leave-One-Out-Cross-Validation (LOOCV), respectively, which consistently outperforms other related methods (KATZHMDA, WP, CMF and Kron RLS). We think WPCMF is ideal as a supplement in the field of biomedical research.","PeriodicalId":7412,"journal":{"name":"American Journal of Biochemistry and Biotechnology","volume":"65 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Biochemistry and Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3844/ajbbsp.2021.502.508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Corresponding Author: Ying Xiao Hunan Chemical Vocational Technology College, Zhuhou, China Email: lingzhi0825@yeah.net Abstract: Previous studies have shown that diseases are associated with microbe. To explore a more effective treatment for these diseases, unknown microbe-drug associations must be identified. However, existing models to identify microbe-drug association are limited. In our article, a predictive model (WPCMF) is presented for identifying microbe-drug associations based on weighted profile and collaborative matrix factorization. In WPCMF, the Gaussian Interaction Profile (GIP) can be used for computing the similarities of microbe and the drug, respectively. Then we use the Canonical SMILES of drugs to compute the chemical structures similarity of drugs. Two drug similarities are fused into an integrated drug similarity matrix. Weighted profile and collaborative matrix factorization are applied for predicting potential microbe-drug associations. Experimental results show that WPCMF achieves the average Area Under the Curve (AUC) values of 0.9096±0.0028, 0.9195±0.0019 and 0.9236 in 5-fold Cross-Validation (5 CV), 10-fold Cross-Validation (10 CV) and Leave-One-Out-Cross-Validation (LOOCV), respectively, which consistently outperforms other related methods (KATZHMDA, WP, CMF and Kron RLS). We think WPCMF is ideal as a supplement in the field of biomedical research.
基于加权轮廓和协同矩阵分解的微生物-药物关联鉴定
通讯作者:肖颖湖南化工职业技术学院,株洲Email: lingzhi0825@yeah.net摘要:以往的研究表明,疾病与微生物有关。为了探索对这些疾病更有效的治疗方法,必须确定未知的微生物-药物关联。然而,现有的识别微生物-药物关联的模型是有限的。在我们的文章中,提出了一种基于加权剖面和协同矩阵分解的预测模型(WPCMF)来识别微生物与药物的关联。在WPCMF中,高斯相互作用谱(GIP)可以分别用于计算微生物和药物的相似度。然后利用药物的正则smile来计算药物的化学结构相似度。两个药物相似度被融合成一个集成的药物相似度矩阵。加权剖面和协同矩阵分解用于预测潜在的微生物-药物关联。实验结果表明,WPCMF在5倍交叉验证(5 CV)、10倍交叉验证(10 CV)和LOOCV上的平均曲线下面积(AUC)分别为0.9096±0.0028、0.9195±0.0019和0.9236,始终优于其他相关方法(KATZHMDA、WP、CMF和Kron RLS)。我们认为WPCMF是生物医学研究领域的理想补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Biochemistry and Biotechnology
American Journal of Biochemistry and Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
0.70
自引率
0.00%
发文量
27
期刊介绍: :: General biochemistry :: Patho-biochemistry :: Evolutionary biotechnology :: Structural biology :: Molecular and cellular biology :: Molecular medicine :: Cancer research :: Virology :: Immunology :: Plant molecular biology and biochemistry :: Experimental methodologies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信